Is a presynaptic pattern in myasthenia gravis an overlap syndrome?

Slides:



Advertisements
Similar presentations
Human Cellular Physiology PHSI3004/3904 Secreted signals and synaptic transmission Dr Bill Phillips Dept of Physiology, Anderson Stuart Bldg Rm N348.
Advertisements

Julie Silverman, MD and Susan Merel, MD University of Washington Lambert Eaton Myasthenic Syndrome: An Elusive Diagnosis Patient underwent extensive cardiopulmonary.
Dr. Emmanuel Fournier La Salpêtrière Hospital, Paris, France
Muscle weakness Index case Year 1 Michaelmas Term.
Oddities – unusual non-motor symptoms in 3 ALS patients Authors: Muhammad Khan, MD, Rajan Patel, MD, Katalin Scherer, MD(Associate Professor of Neurology,
Myasthenia gravis in the elderly Johan A. Aarli University of Bergen, Norway.
EMG Blind Spots: What Your Study Can Miss Disorders of the NMJ W. David Arnold, MD AAPMR 2014.
Therapeutic Plasma Exchange for Myasthenia Gravis Clifford Blieden, MD Houston Methodist Hospital Department of Pathology and Genomic Medicine, Division.
NEUROMUSCULAR JUNCTION BLOCKERS BY :DR ISRAA OMAR.
Lambert Eaton: An Elusive Diagnosis
GENERAL THORACIC SURGERY CHAPTER 168
SKELETAL MUSCLE PATHOLOGY. Normal skeletal muscle.
Xeloda ® plus oxaliplatin: rationale in colorectal cancer (CRC)  Oxaliplatin is active in CRC, especially when combined with 5-FU/leucovorin (LV)  Superior.
Floppy Adolescent Joshua Rocker, MD Schneider Children’s Hospital Long Island Jewish Medical Center.
Sophia M. Chung, M.D. Depts of Ophthalmology &
Myasthenia Gravis Victor Politi,M.D.
Neurotransmitter Types Scanned from Squires et. al. Fundamental Neuroscience.
NEUROMUSCULAR JUNCTION BLOCKERS
Neuromuscular Signs and Symptoms: Muscle stiffness, ptosis, axial muscle weakness 1 W. David Arnold, MD AAPMR 2015 Disclosure: I receive funding through.
Disorders of the Neuromuscular Junction
ENDOCRINE MANIFESTATION OF MALAGNANCY PARANEOPLASTIC SYNDROME
Myasthenia Gravis: An inheritable disorder or an acquired auto-immune response Research in Allied Health Jeri Frazier November 1, 2005.
NEUROPATHY Subsection B3 Francisco – Go, Kerby + Laxamana September 16, 2009.
MYASTHENIA GRAVIS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
Approach to the Patient with Weakness. What are clinical features that might lead you to believe that weakness is peripheral? Why is it important to localize.
CRITICAL ILLNESS NEUROMYOPATHY
Celiac Disease: Neurological Manifestations in 2 undiagnosed patients Kogulavadanan Arumaithurai MD, Ashish Kapoor MD, Holli Horak MD, Katalin Scherer.
神经肌接头病 (Disorders of neuromuscular transmission) 重症肌无力 Lambert-Eaton 综合征 Dep. of Neurology The 2nd Hospital Harbin Medical University.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Presence and Pathogenic Relevance of Antibodies to.
Neuromuscular disorders
Audio-spinal reflex response in human limb muscles
Brain imaging prior to lung cancer resection
Myasthenia Gravis.
71-year-old Man with Nystagmus and Oscillpsia
Neuromuscular junction
Dr. Emmanuel Fournier La Salpêtrière Hospital, Paris, France
Primitive Ano-rectal area melanoma:Case Report
The Patch Clamp Method 1976 by Erwin Neher and Bert Sakmann at the Max Planck Institute in Goettingen.
Contact: PC097 Case report: Hyperthermia and rhabdomyolysis of unknown origin, a ryanodine receptor problem? H.A.R. Biersteker¹,
Dr. Emmanuel Fournier La Salpêtrière Hospital, Paris, France
Keith E. Kelly, MD and William H. Culbertson, MD
Brain imaging prior to lung cancer resection
“Outcome measures in Autoimmune NMJ Diseases” Renato Mantegazza Dept
Treatment With Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART) For Non-Small Cell Lung Cancer (NSCLC): The Weston Park Hospital Experience.
Myasthenia gravis By: Nikki Young.
Presenter : Dr Aneelraj Co investigators : Dr Srikala Bharath
163-1 Myasthenia/Thymoma.
Neuromuscular Junction Disorders
M Waddington Cruz, A Berensztejn, MV Pinto, R Mundayat
EMG.
Stimulated single-fiber electromyography (sSFEMG) in Lambert-Eaton syndrome  Vincenzo Todisco, Giovanni Cirillo, Rocco Capuano, Alessandro d'Ambrosio,
Volume 10, Issue 12, Pages (December 2011)
Figure 1 Neuromuscular junction in myasthenia gravis (MG)
(A) This 54 year old man with the flail arm syndrome has severe wasting of the arms causing profound weakness. (A) This 54 year old man with the flail.
Figure 2 Clinical course and response to therapy in 6 Australian patients with HMGCR antibodies The clinical course, creatine kinase (CK) levels, Medical.
Figure 1 Clinical aspects of LGMD subtypes
Big Data Reveal Insights into Alopecia Areata Comorbidities
 These traces show typical electrophysiological features of a pre-synaptic neuromuscular transmission disorder in a patient with LEMS. The traces on the.
Neurology Resident and Fellow Section
Muscle Diseases and Disorders
Analysis of PD-L1 tumour-cell membrane staining concordance between PD-L1 immunohistochemistry 22C3 and 28-8 assays across all matched tumour biopsies.
Archives of Physical Medicine and Rehabilitation
Electrophysiologic and MR changes in L5 nerve root lesion.
Dendritic Sodium Spikes Are Variable Triggers of Axonal Action Potentials in Hippocampal CA1 Pyramidal Neurons  Nace L Golding, Nelson Spruston  Neuron 
Marianne Arzel-Hézode, Emmanuel Fournier
Lambert-Eaton Myasthenic Syndrome (LEMS)
Diagrammatic representation of neuromuscular transmission.
Presentation transcript:

Is a presynaptic pattern in myasthenia gravis an overlap syndrome? P.E. Alboini; V. Damato; R. Iorio; M. Luigetti; A. Evoli Istituto di Neurologia, Università Cattolica del Sacro Cuore – Roma Introduction Myasthenia gravis (MG) and the Lambert-Eaton myasthenic syndrome (LEMS) are characterized by different clinical, neurophysiological and immunological features. Auto-antibodies (Abs) directed against post-synaptic membrane are detected in MG (acetylcholine receptor (AChR) in 85% of cases; muscle-specific kinase (MuSK) in 5-8% and lipoprotein receptor-related protein 4 (Lrp4) in a low proportion of cases); whereas in LEMS auto-Abs, directed against the voltage gated calcium channels (VGCC) of pre-synaptic membrane, are observed in large majority of cases (85-90%). Bulbar involvement is frequent in MG. Limb proximal weakness, hypo/areflexia, autonomic dysfunction and the association with small cell lung cancer (SCLC) are the main characteristics of LEMS. We report two cases with a clinical diagnosis of MG and neurophysiological features consistent with a pre-synaptic defect of neuromuscular transmission. We reviewed English literature studies on co-existing features of MG and LEMS, and discuss diagnostic controversies. Case reports A 46 year-old woman and a 56 year-old man diagnosed with generalized MG were referred to our Institution. Both patients had weakness predominant in limb proximal muscles, electrophysiological studies showing a presynaptic pattern (+400% and +135% respectively) (Figure 1), no autonomic dysfunction, positive results on AChR Ab assay and undetectable VGCC Abs. Both patients improved on cholinesterase inhibitors (ChE-Is), 3,4-diaminopyridine (3,4-DAP) was ineffective; steroid treatment led to good control of symptoms. No associated tumours were found in the female patient during the 9-year follow up; whereas in the male patient, a PET/CT scan detected, at 21 months from the disease onset, an increased activity in the caecum (a biopsy revealed a carcinoma in situ). Table 1 Studies Age/ Gender Weakness Hypo/ areflexia Autonomic dysfunction Antibodies EMG pattern Response to Oculo-bulbar Limb AChR VGCC ChE-Is 3,4-DAP Takamori, 1972 33/F +  n.d. presynaptic 32/F 33/M 56/F Dahl, 1974 13/M Oh, 1974 63/M Schwartz, 1975 47/F Mori, 1976 50/M Cherrington, 1976 43/M Fettel, 1978 58/M Singer, 1981 58/F Tabaa, 1986 42/M normal Sanders, 1987 77/M n.r. 41/F 51/F 48/M n.r 61/M presynaptic* 55/M postsynaptic Taphroon, 1988 80/F Brenna, 1988 Newsom-Davis, 1991 59/M 31/F Katz, 1998 66/M Kanzato, 1999 57/M Matsumoto, 1999 60/M Patel, 2004 21/F Oh, 2005 26/F Roohi, 2006 70/F Sha, 2007 18/F Basta, 2012 56/M  (MuSK+) Iqbal, 2012 73/F Kim, 2012 48/F Lee, 2012 Kurt, 2013 52/F Our patients 46/F Legend. Shaded areas show patients with both MG and LEMS specific antibodies. *EMG pattern changed into post-synaptic after cancer treatment Figure 1 Legend. Nerve conduction studies of peroneal nerve, recording from tibialis anterior, of male patient. Upper traces: CMAP at rest (1.4 mV for right nerve in a, and 1.3 mV for left nerve in b). Lower traces: CMAP after brief exercise (3.3 mV for right nerve in a, and 3.1 for left nerve in b). A significant increment of CMAP amplitude is shown (around 135% for both nerves). Results To date 36 patients (18 men and 18 women) with co-existing features of MG and LEMS have been described in the English literature. In 22 (61%) clinical and electrophysiological findings of MG and LEMS occurred simultaneously. Oculo-bulbar symptoms and limb weakness had the same frequency (in 35/36 patients, 97%). Tendon reflexes were hypo-evocable in 23 patients (64%); dysautonomia was reported in ten (28%). On electrophysiological studies, 33 cases (92%) had a pre-synaptic pattern; two a post-synaptic defect (SCLC was found in both cases); no neuro-muscular transmission defect was detected in one patient, (both AChR and VGCC Abs were present). AChR Abs were positive in 20/24 (83%) and VGCC Abs in 8/12 (66%) tested patients; both AChR and VGCC Abs were present in six patients; MuSK and VGCC Abs in a single case. Twenty-seven patients tried ChE-Is, with a definite improvement in 20 (88%); no patient responded to 3,4-DAP alone, but a combination of 3,4-DAP and ChE-Is was beneficial in four cases (Table 1). Five SCLCs and one thymoma were recorded. Discussion and conclusion The coexistence of MG and LEMS (overlap syndrome) is controversial. In earlier studies, this entity was diagnosed on the association of oculo-bulbar symptoms, response to ChE-Is, proximal limb weakness, reduced tendon reflexes and a presynaptic pattern on neurophysiological studies. Currently, the diagnosis of “true” overlap syndrome should be reserved to patients with immunological confirmation of both MG and LEMS, even though negative results on Abs assays do not exclude each single diagnosis (Figure 2). Whether a pre-synaptic pattern in MG patients represents an indication for tumour-screening as recommended in LEMS warrants further studies. This protocol proved very useful in our male patient in whom PET-CT scan detected a bowel carcinoma in situ. The distinction between MG with pre-synaptic pattern and overlap syndrome and the underlying mechanisms are still undefined. Figure 2 Myasthenia gravis AChR (MuSK) Abs Oculo-bulbar symptoms Response to ChE-Is Thymus changes Post-synaptic EMG pattern Lambert-Eaton myasthenic syndrome VGCC Abs Autonomic symptoms SCLC Proximal limb weakness Pre-synaptic pattern on EMG References Newsom-Davis J et al. J Neurol Neurosurg Psychiatry 1991;54:452-453 Oh SJ, Sher E. Clin Neurophysiol 2005;116:1167-1171 Titulaer MJ et al. Lancet Neurol. 2011;10:1098-1107 Lennon VA. Neurology 1997;Suppl5:23S-27S Sanders DB, Stalberg E. Ann N Y Acad Sci. 1987;505:864-865 Basta I et al. Clin Neurol Neurosurg. 2012;114:795-797. Howard JF Jr.. Phys Med Rehabil Clin N Am 2013;24:169-192. Legend. The dashed box collects the main characteristics of reviewed patients with MG and LEMS features XLVI CONGRESSO NAZIONALE 10-13 OTTOBRE 2015 – GENOVA